Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $595.94M.
ENTERPRISE VALUE (EV)
$595.94M
Vor Biopharma Inc.
Market Cap
$992.14M
Enterprise Value (EV)
$595.94M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vor Biopharma Inc. (VOR) | $992.14M | $595.94M |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $995.51M | $845.10M |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | $922.12M |
| Immatics N.V. (IMTX)vs › | $1.01B | $756.61M |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.22M | $701.33M |
| MeiraGTx Holdings plc (MGTX)vs › | $978.24M | $947.40M |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $971.74M | $1.18B |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | $993.67M |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | $1.02B |
Market Cap
$992.14M
Total Debt
$280000.00
Cash
$396.49M
Enterprise Value
$595.94M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
